Pharmaceutical News and Articles
Comprehensive and up-to-date drug news for both consumers and healthcare professionals.
Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.
Daily MedNews
-- Here are the latest clinical trials, courtesy of CenterWatch:
Multiple Sclerosis
If you are aged 18 to 55 and have a confirmed diagnosis of relapsing-remitting multiple sclerosis with at least one relapse in the past 12 months, you may qualify...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay:
Minorities More Likely to Suffer Corporal Punishment in Schools
Minority children received a disproportionate share of the corporal punishment given...
WEDNESDAY, Aug. 20 -- It may be time to add calcium to the types of tastes -- sweet, sour, salty, bitter and savory -- that can be detected by humans, according to U.S. researchers.
They found that a taste for calcium exists in mice. Since mice and...
WEDNESDAY, Aug. 20 -- Vigabatrin, a medication that holds potential as a treatment for drug addiction, has been found to cause rapid weight loss in animals.
A study done by U.S. Department of Energy's (DOE) Brookhaven National Laboratory found that...
WEDNESDAY, Aug. 20 -- Working-age Americans are facing mounting problems when it comes to affording health care, a result of what analysts are calling a "perfect storm" of economic woes.
In 2007, 41 percent of working-age Americans -- 72 million...
Pharma Industry News
SAN DIEGO--(BUSINESS WIRE)--Aug 20, 2008 - A Virginia man yesterday filed what is believed to be the first personal injury lawsuit stemming from injuries associated with the use of Byetta(R), an injectable medication for diabetes. Victor Deleon...
Elotuzumab Antibody Designed to Target Highly Expressed Cell Surface Protein and Selectively Kill Multiple Myeloma Cells
//
PRINCETON, N.J. & REDWOOD CITY, Calif., August 19, 2008 - Bristol-Myers Squibb Company (NYSE: BMY) and PDL...
NEW YORK, August 19, 2008 – Men with signs of benign prostatic hyperplasia (BPH) can be helped with a daily dose of erectile dysfunction drug tadalafil (Cialis®) to relieve associated lower urinary tract symptoms (LUTS), according to a new...
ASMANEX is the first and only once-daily inhaled corticosteroid inhaler approved for children as young as age 4
KENILWORTH, N.J., August 19, 2008 /PRNewswire-FirstCall/ -- Schering-Plough Corporation announced today that ASMANEX(R) TWISTHALER(R) 110...
Information for Healthcare Professionals
Exenatide (marketed as Byetta)
Update 8/18/2008: Since issuing Information for Healthcare Professionals in October 2007, FDA has received reports of 6 cases of hemorrhagic or necrotizing...
New Drug Approvals
WASHINGTON, August 15, 2008 /PRNewswire/ -- Prestwick Pharmaceuticals, Inc., a privately-held pharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has approved Xenazine (tetrabenazine) for the treatment of chorea...
FOSTER CITY, Calif.--(BUSINESS WIRE)--Aug 11, 2008 - Gilead Sciences, Inc. today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Viread (tenofovir disoproxil fumarate) for the treatment of chronic...
First New IV Antihypertensive Treatment Approved in Ten Years
PARSIPPANY, N.J.--(BUSINESS WIRE)--The Medicines Company announced today that the U.S. Food and Drug Administration (FDA) has approved the intravenous (IV) therapy Cleviprex (clevidipine...
Approvals consistent with current US treatment guidelines to start appropriate patients on combination therapies
EAST HANOVER, N.J., August 04, 2008 /PRNewswire/ -- The US Food and Drug Administration (FDA) has approved two single-pill combination...
CEDAR KNolls, NJ, Aug. 1, 2008-EKR Therapeutics, Inc., a specialty pharmaceutical company focused on providing novel products for the acute-care hospital setting, today announced that it received FDA approval for Cardene I.V. (nicardipine...
New Drug Applications
VANCOUVER and DEERFIELD, IL, August 11, 2008 /PRNewswire-FirstCall/ - Cardiome Pharma Corp. and its co-development partner Astellas Pharma US, Inc. ("Astellas") today announced that they have received an action letter dated August 8, 2008 from the...
BRIDGEWATER, N.J., August 08, 2008 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that U.S. Food and Drug Administration (FDA) has assigned priority review status for its New Drug Application (NDA) for Multaq (dronedarone). The priority...
HORSHAM, Pa., August 08, 2008 /PRNewswire/ -- Centocor, Inc., today announced that the U.S. Food and Drug Administration (FDA) has extended the review timeline for the Biologic License Application for ustekinumab, a subcutaneous biologic therapy, by...
EXTON, Pa.--(BUSINESS WIRE)--Jul 30, 2008 - Othera Pharmaceuticals, Inc., announced today the submission of an Investigational New Drug (IND) application to the U.S. Food and Drug Administration (FDA) for OT-730, an oculoselective beta-blocker, as a...
FRAMINGHAM, Mass.--(BUSINESS WIRE)--Aug 7, 2008 - GTC Biotherapeutics, Inc. has completed its submission of the final portion of the Biologics License Application, or BLA, for ATryn in the United States. The final portion of the BLA submission...
Clinical Trials
TheraQuest Presents Topical Local Anesthetic and Abuse Deterrence Data at the World Congress on Pain
BLUE BELL, Pa., August 20, 2008 /PRNewswire/ -- TheraQuest Biosciences, Inc. a development stage pain management company is presenting data today on TQ-1019, its proprietary topical local anesthetic and on SECUREL(R), its abuse deterrent technology...
PHILADELPHIA, August 20, 2008 /PRNewswire/ -- Peer-reviewed safety and efficacy data on Electrical Twitch Obtaining Intramuscular Stimulation (eToims(R)), successfully applied to patients suffering from treatment-resistant chronic pain appeared in...
SYDNEY, Australia, August 20, 2008 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis today announced that the Phase 3 clinical trial evaluating the long term safety of Bronchitol in subjects with bronchiectasis has concluded with no...
WORCESTER, Mass.--(BUSINESS WIRE)--Aug 19, 2008 - Advanced Cell Technology, Inc. ("ACT") (OTC: ACTC.PK) reported that it is feasible to differentiate and mature human embryonic stem cells (hESCs) into functional oxygen-carrying red blood cells...
AZUSA, Calif.--(BUSINESS WIRE)--Aug 19, 2008 - Viral Genetics, Inc. (Other OTC:VRAL), a biotechnology company that discovers and develops immune-based therapies, today unveiled a new theory regarding a potential mechanism of action, which could...
More News Resources
Daily MedNews
Pharma Industry News
New Drug Applications
New Drug Approvals
Clinical Trial Results
Generic Drug Approvals
